The use of molecular profiling to predict survival after chemotherapy for diffuse large-B-cell lymphoma.
暂无分享,去创建一个
Meland | L. Staudt | A. Rosenwald | J. Powell | Liming Yang | W. Chan | T. Greiner | D. Weisenburger | J. Armitage | W. Wilson | oseph | J. Vose | R. Gascoyne | A. López-Guillermo | E. Campo | E. Montserrat | J. Connors | George W. Wright | G. Ott | H. Muller-Hermelink | E. Jaffe | J. Delabie | E. Smeland | R. Fisher | R. Simon | J. Giltnane | E. Hurt | Hong Zhao | Lauren Averett | R. Klausner | P. Duffey | D. Longo | W. Sanger | B. Dave | J. Lynch | T. Grogan | T. Miller | S. Kvaløy | H. Holte | P. Krajči | T. Stokke | C. C. | Han | C. M. | Onnors | ichard | F. I. | Isher | Andy | G. D. | Ascoyne | K. H | onrad | uller | H. – | Ermelink | Rlend | S. B | Ouis | S. M. | Taudt | S. B. | ing | M. LeBlanc | H | ING | C. C. | HAN | OSEPH | C M. | ONNORS | ICHARD | F I. | ISHER | ANDY | G D. | ASCOYNE | K H. | ONRAD | ULLER | ERMELINK | RLEND | S B. | MELAND | OUIS | S M. | TAUDT | W. Wilson | R. Simon
[1] Ash A. Alizadeh,et al. The t(14;18) defines a unique subset of diffuse large B-cell lymphoma with a germinal center B-cell gene expression profile. , 2002, Blood.
[2] Ulrich Siebenlist,et al. Constitutive Nuclear Factor κB Activity Is Required for Survival of Activated B Cell–like Diffuse Large B Cell Lymphoma Cells , 2001, The Journal of experimental medicine.
[3] L. Staudt,et al. Signatures of the immune response. , 2001, Immunity.
[4] A. Baldwin. Control of oncogenesis and cancer therapy resistance by the transcription factor NF-kappaB. , 2001, The Journal of clinical investigation.
[5] T. Lister,et al. The use of real‐time quantitative polymerase chain reaction and comparative genomic hybridization to identify amplification of the REL gene in follicular lymphoma , 2000, British journal of haematology.
[6] Ash A. Alizadeh,et al. Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling , 2000, Nature.
[7] R. Fisher. Diffuse large-cell lymphoma. , 2000, Annals of oncology : official journal of the European Society for Medical Oncology.
[8] J. Armitage,et al. International Consensus Conference on high-dose therapy with hematopoietic stem-cell transplantation in aggressive non-Hodgkin's lymphomas: report of the jury. , 1999, Annals of oncology : official journal of the European Society for Medical Oncology.
[9] Ash A. Alizadeh,et al. The lymphochip: a specialized cDNA microarray for the genomic-scale analysis of gene expression in normal and malignant lymphocytes. , 1999, Cold Spring Harbor symposia on quantitative biology.
[10] D. Botstein,et al. Cluster analysis and display of genome-wide expression patterns. , 1998, Proceedings of the National Academy of Sciences of the United States of America.
[11] Emili Montserrat,et al. A predictive model for aggressive non-Hodgkin's lymphoma. , 1993, The New England journal of medicine.
[12] F. Rilke,et al. Cell proliferation as a long‐term prognostic factor in diffuse large‐cell lymphomas , 1993, International journal of cancer.
[13] T M Grogan,et al. Comparison of a standard regimen (CHOP) with three intensive chemotherapy regimens for advanced non-Hodgkin's lymphoma. , 1993, The New England journal of medicine.
[14] M. Raffeld,et al. Detection of occult follicular lymphoma by specific DNA amplification. , 1988, Blood.
[15] T. Grogan,et al. HLA-DR (Ia) immune phenotype predicts outcome for patients with diffuse large cell lymphoma. , 1988, The Journal of clinical investigation.
[16] T. Grogan,et al. Independent prognostic significance of a nuclear proliferation antigen in diffuse large cell lymphomas as determined by the monoclonal antibody Ki-67. , 1988, Blood.